MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · IEX Real-Time Price · USD
4.670
-0.130 (-2.71%)
May 17, 2024, 4:00 PM EDT - Market closed
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $491.88 million as of May 17, 2024. Its market cap has increased by 27.96% in one year.
Market Cap
491.88M
Enterprise Value
353.01M
1-Year Change
27.96%
Ranking
Category
Stock Price
$4.67
Market Cap Chart
Since the IPO on July 30, 2021, MaxCyte's market cap has decreased from $897.06M to $491.88M, a decrease of -45.17%. That is a compound annual growth rate of -19.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 488.20M | -2.71% |
May 16, 2024 | 501.80M | 0.62% |
May 15, 2024 | 498.70M | 5.08% |
May 14, 2024 | 474.60M | -3.61% |
May 13, 2024 | 492.40M | -0.63% |
May 10, 2024 | 495.50M | 0.20% |
May 9, 2024 | 494.50M | 1.94% |
May 8, 2024 | 485.10M | 18.06% |
May 7, 2024 | 410.90M | 0.93% |
May 6, 2024 | 407.10M | 3.69% |
May 3, 2024 | 392.60M | -1.55% |
May 2, 2024 | 398.80M | 1.32% |
May 1, 2024 | 393.60M | 4.13% |
Apr 30, 2024 | 378.00M | -0.81% |
Apr 29, 2024 | 381.10M | -1.35% |
Apr 26, 2024 | 386.30M | 0.55% |
Apr 25, 2024 | 384.20M | -1.34% |
Apr 24, 2024 | 389.40M | -1.59% |
Apr 23, 2024 | 395.70M | -4.03% |
Apr 22, 2024 | 412.30M | 0.24% |
Apr 19, 2024 | 411.30M | 1.81% |
Apr 18, 2024 | 404.00M | -1.54% |
Apr 17, 2024 | 410.30M | -1.25% |
Apr 16, 2024 | 415.50M | 2.85% |
Apr 15, 2024 | 404.00M | -3.00% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cibus | 511.04M |
Aveanna Healthcare Holdings | 509.80M |
Ocugen | 509.51M |
KalVista Pharmaceuticals | 509.00M |
Entrada Therapeutics | 505.71M |
Travere Therapeutics | 505.12M |
Verve Therapeutics | 502.32M |
Corbus Pharmaceuticals Holdings | 491.96M |